Reference | 1: Sawant TB, Wakchaure VS, Rakibe UK, Musmade PB, Chaudhari BR, Mane DV. The
Development and Validation of Novel, Simple High-Performance Liquid
Chromatographic Method with Refractive Index Detector for Quantification of
Memantine Hydrochloride in Dissolution Samples. J Chromatogr Sci. 2017 Jul
1;55(6):603-609. doi: 10.1093/chromsci/bmx013. PubMed PMID: 28334787.
<br>
2: A Prospective Open-Label Trial of Memantine Hydrochloride for the Treatment of
Social Deficits in Intellectually Capable Adults With Autism Spectrum Disorder:
Erratum. J Clin Psychopharmacol. 2016 Aug;36(4):339. doi:
10.1097/JCP.0000000000000534. PubMed PMID: 27355795.
<br>
3: Joshi G, Wozniak J, Faraone SV, Fried R, Chan J, Furtak S, Grimsley E, Conroy
K, Kilcullen JR, Woodworth KY, Biederman J. A Prospective Open-Label Trial of
Memantine Hydrochloride for the Treatment of Social Deficits in Intellectually
Capable Adults With Autism Spectrum Disorder. J Clin Psychopharmacol. 2016
Jun;36(3):262-71. doi: 10.1097/JCP.0000000000000499. PubMed PMID: 27043118.
<br>
4: Sahu A, Narayanam M, Kurmi M, Ladumor MK, Singh S. Quantitation of memantine
hydrochloride bulk drug and its tablet formulation using proton nuclear magnetic
resonance spectrometry. Magn Reson Chem. 2016 Aug;54(8):632-6. doi:
10.1002/mrc.4421. Epub 2016 Feb 28. PubMed PMID: 26923624.
<br>
5: Jing SJ, Li QL, Jiang Y. A new simultaneous derivatization and microextration
method for the determination of memantine hydrochloride in human plasma. J
Chromatogr B Analyt Technol Biomed Life Sci. 2016 Jan 1;1008:26-31. doi:
10.1016/j.jchromb.2015.09.016. Epub 2015 Nov 5. PubMed PMID: 26613537.
<br>
6: Kurz A, Grimmer T. Efficacy of memantine hydrochloride once-daily in
Alzheimer/’s disease. Expert Opin Pharmacother. 2014 Sep;15(13):1955-60. doi:
10.1517/14656566.2014.945907. Epub 2014 Aug 1. PubMed PMID: 25085661.
<br>
7: Zhu M, Xiao S, Li G, Li X, Tang M, Yang S, Xu X, Feng L, Liu K, Hu L.
Effectiveness and safety of generic memantine hydrochloride manufactured in China
in the treatment of moderate to severe Alzheimer/’s disease: a multicenter,
double-blind randomized controlled trial. Shanghai Arch Psychiatry. 2013
Aug;25(4):244-53. doi: 10.3969/j.issn.1002-0829.2013.04.006. PubMed PMID:
24991162; PubMed Central PMCID: PMC4054562.
<br>
8: Jalalizadeh H, Raei M, Tafti RF, Farsam H, Kebriaeezadeh A, Souri E. A
Stability-Indicating HPLC Method for the Determination of Memantine Hydrochloride
in Dosage Forms through Derivatization with 1-Fluoro-2,4-dinitrobenzene. Sci
Pharm. 2013 Dec 9;82(2):265-79. doi: 10.3797/scipharm.1310-09. Print 2014
Apr-Jun. PubMed PMID: 24959398; PubMed Central PMCID: PMC4065122.
<br>
9: Kitamura S, Nakamura Y, Homma A, Kimura N, Asami Y. Tolerability and efficacy
of the long-term administration of memantine hydrochloride (Memary®) in patients
with moderate to severe Alzheimer/’s disease. Nihon Ronen Igakkai Zasshi.
2014;51(1):74-84. Japanese. PubMed PMID: 24747504.
<br>
10: Peng D, Yuan X, Zhu R. Memantine hydrochloride in the treatment of dementia
subtypes. J Clin Neurosci. 2013 Nov;20(11):1482-5. doi:
10.1016/j.jocn.2013.02.041. Epub 2013 Sep 13. Review. PubMed PMID: 24035650.
|